Literature DB >> 15659746

Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

Giuseppe Gerna1, Elena Percivalle1, Daniele Lilleri1, Laura Lozza1, Chiara Fornara1, Gabriele Hahn2, Fausto Baldanti1, M Grazia Revello1.   

Abstract

Human cytomegalovirus (HCMV) genetic determinants of endothelial-cell tropism and virus transfer to leukocytes (both polymorphonuclear and monocyte) have been recently identified in the UL131-128 genes. Here it is documented that the same genetic determinants of HCMV are responsible for monocyte-derived dendritic-cell (DC) tropism, i.e. all endotheliotropic and leukotropic strains of HCMV are also DC-tropic (or dendrotropic). In fact, all recent clinical HCMV isolates and deletion mutants sparing the UL131-128 locus as well as the endotheliotropic revertants AD169 and Towne were able to productively infect DC following co-culture with infected endothelial cells. On the contrary, the same clinical isolates extensively propagated in human fibroblasts, the UL131-128 deletion mutants and the reference laboratory strains were not. Peak extracellular virus titres in DC were reached 4-7 days post-infection (p.i.). Viral proteins pp65 and p72 were detected 1-3 h p.i., involving the great majority of DC 24 h p.i., while gB was abundantly detected 96 h p.i., when a cytopathic effect first appeared. Infection of DC with cell-free virus released into the medium could only be achieved with HCMV strains extensively adapted to growth in endothelial cells, reaching the peak titres 10 days p.i. DC infected for 24 h with cell-free virus and incubated for 16 h with autologous peripheral blood mononuclear cells were found to act as a potent stimulator of both HCMV-specific CD4+- and CD8+-mediated immune responses, as determined by cytokine flow cytometry. DC incubated with inactivated crude whole viral antigen preparations were only capable of eliciting a significant CD4+-mediated immune response.

Entities:  

Mesh:

Year:  2005        PMID: 15659746     DOI: 10.1099/vir.0.80474-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  103 in total

1.  RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Authors:  Matthew S Miller; Wendy E Furlong; Leesa Pennell; Marc Geadah; Laura Hertel
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism.

Authors:  Gang Li; Christopher C Nguyen; Brent J Ryckman; William J Britt; Jeremy P Kamil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 3.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

4.  Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.

Authors:  Xiaohong Cui; Stuart P Adler; Mark R Schleiss; Ravit Arav-Boger; Gail J Demmler Harrison; Michael A McVoy
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

5.  Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells.

Authors:  Adam L Vanarsdall; Marie C Chase; David C Johnson
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 6.  The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Miriam Ciáurriz; Amaya Zabalza; Lorea Beloki; Cristina Mansilla; Estela Pérez-Valderrama; Mercedes Lachén; Eva Bandrés; Eduardo Olavarría; Natalia Ramírez
Journal:  Cell Mol Life Sci       Date:  2015-07-15       Impact factor: 9.261

7.  Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.

Authors:  Xiaohong Cui; Daniel C Freed; Dai Wang; Ping Qiu; Fengsheng Li; Tong-Ming Fu; Lawrence M Kauvar; Michael A McVoy
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

8.  Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Authors:  Emma Poole; Ian Groves; Andrew MacDonald; Yin Pang; Antonio Alcami; John Sinclair
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

10.  A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.

Authors:  Stuart P Adler; Anne-Marie Manganello; Ronzo Lee; Michael A McVoy; Daniel E Nixon; Stanley Plotkin; Edward Mocarski; Josephine H Cox; Patricia E Fast; Pavlo A Nesterenko; Susan E Murray; Ann B Hill; George Kemble
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.